Completion and Adverse Drug Events of Latent Tuberculosis Infection Treatment in Patients Receiving Dialysis: Predictors and Impacts of Different Regimens in a Prospective Cohort Study
Shu‐Yung Lin, Jia‐Yih Feng, Chih‐Yuan Lee, Yi‐Chih Lin, Yu‐Hsiang Chou, Kuan‐Yin Lin, Yufeng Wei, Shu‐Wen Lin, et al. (13 authors)
Antimicrobial Agents and Chemotherapy · 2020-12
Abstract
Although patients with end-stage renal disease receiving maintenance hemodialysis are at high risk for tuberculosis, the optimal treatment regimen for latent tuberculosis infection (LTBI) in this group has scarcely been studied for predictors of completion rate and adverse drug events (ADE). We prospectively enrolled dialysis patients for LTBI intervention from three medical centers in Taiwan.
MeSH terms
- Medicine
- Latent tuberculosis
- Tuberculosis
- Dialysis
- Regimen
- Prospective cohort study
- Adverse effect
- Internal medicine
- Hemodialysis
- Cohort
- Rifapentine
- Cohort study
- Surgery
- Intensive care medicine